Anzeige
Mehr »
Samstag, 13.06.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EE4D | ISIN: KYG5880S1131 | Ticker-Symbol:
NASDAQ
12.06.26 | 21:58
0,167 US-Dollar
+0,06 % +0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
PING AN BIOMEDICAL CO LTD Chart 1 Jahr
5-Tage-Chart
PING AN BIOMEDICAL CO LTD 5-Tage-Chart

Aktuelle News zur PING AN BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.05.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer2
19.03.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer5
19.03.Aktionäre von Ping An Biomedical genehmigen duale Aktienstruktur1
19.03.Ping An Biomedical shareholders approve dual-class share structure1
19.03.Ping An Biomedical Co., Ltd: All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital209HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that shareholders have approved all five resolutions at...
► Artikel lesen
PING AN BIOMEDICAL Aktie jetzt für 0€ handeln
09.03.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer2
13.02.Ping An Biomedical Co., Ltd. - F-1, Registration statement for certain foreign private issuers-
12.02.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer1
30.01.Ping An Biomedical Co., Ltd. - 20-F, Annual and transition report of foreign private issuers1
12.01.Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer-
09.01.Ping An Biomedical: Aktie stürzt nach 90-Millionen-Dollar-Investitionsplan ab10
09.01.Ping An Biomedical Co., Ltd.: Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry645HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the...
► Artikel lesen
09.01.Ping An Biomedical secures investment from three notable investors1
09.01.Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation333HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase...
► Artikel lesen
28.11.25Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter187Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the "Company") today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025...
► Artikel lesen
12.09.25Majestic Ideal Holdings Ltd. Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting402HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the "Company") announced that during the Extraordinary General Meeting of Shareholders (the "Meeting") held...
► Artikel lesen
22.07.25Majestic Ideal Holdings Ltd. Announced Closing of Initial Public Offering445NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the "Company"), a provider of SCM services in the apparel industry delivering one-stop solution, today announced...
► Artikel lesen
18.07.25Majestic Ideal Holdings Ltd. Announces Pricing of Initial Public Offering and Listing on Nasdaq606NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the "Company"), a provider of SCM services in the apparel industry delivering one-stop solution, today announced...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1